Literature DB >> 17372637

The efficiency of sputum cell counts in cystic fibrosis.

L Jayaram1, N R Labiris, A Efthimiadis, H Valchos-Mayer, F E Hargreave, A P Freitag.   

Abstract

BACKGROUND: Technical factors relating to processing viscid sputum in cystic fibrosis (CF) and their influence on the reproducibility and validity of cell counts need to be evaluated. In addition, the methods need to be standardized so that they can be applied clinically and in research.
OBJECTIVE: To examine the efficiency, reliability and validity of processing small volumes of spontaneously expectorated sputum from subjects with CF.
METHODS: Sputum was collected from adults with CF (n=35) and compared with sputum from adults with infective bronchitis or bronchiectasis (IB/B) (n=16), or with asthma or chronic obstructive pulmonary disease (AS/COPD) (n=25). Selected sputum (100 mg to 200 mg) was processed with dithiothreitol (0.1%) and filtered. Total cell count (TCC) and viability were obtained in a counting chamber and cytospins were prepared and stained with Wright's for a differential cell count. Sputum and filter remnant were processed for TCC, viability and differential cell count, and the efficiency was determined by comparing the mean loss in cell yield to the filter. Two different portions from the same sputum sample were processed for cell counts to determine reproducibility. Results were compared with those from IB/B and AS/COPD groups.
RESULTS: Efficiency of cell dispersal was excellent and similar to that in AS/COPD and IB/B groups. Reproducibility of cell counts from two portions of a sputum sample was high (>or=0.80). CF sputum demonstrated a raised TCC and neutrophilia similar to IB/B but significantly higher than AS/COPD.
CONCLUSION: The selection method of evaluating cell counts in viscid CF sputum is efficient, reproducible and valid.

Entities:  

Mesh:

Year:  2007        PMID: 17372637      PMCID: PMC2676380          DOI: 10.1155/2007/679742

Source DB:  PubMed          Journal:  Can Respir J        ISSN: 1198-2241            Impact factor:   2.409


  21 in total

Review 1.  Induced sputum cell counts: their usefulness in clinical practice.

Authors:  L Jayaram; K Parameswaran; M R Sears; F E Hargreave
Journal:  Eur Respir J       Date:  2000-07       Impact factor: 16.671

2.  Comparison of sputum processing techniques in cystic fibrosis.

Authors:  Y Cai; K Carty; P Gibson; R Henry
Journal:  Pediatr Pulmonol       Date:  1996-12

3.  Spontaneous and induced sputum to measure indices of airway inflammation in asthma.

Authors:  M M Pizzichini; T A Popov; A Efthimiadis; P Hussack; S Evans; E Pizzichini; J Dolovich; F E Hargreave
Journal:  Am J Respir Crit Care Med       Date:  1996-10       Impact factor: 21.405

4.  Standardization of Spirometry, 1994 Update. American Thoracic Society.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  1995-09       Impact factor: 21.405

5.  The evaluation of a cell dispersion method of sputum examination.

Authors:  T Popov; R Gottschalk; R Kolendowicz; J Dolovich; P Powers; F E Hargreave
Journal:  Clin Exp Allergy       Date:  1994-08       Impact factor: 5.018

6.  Comparison of spontaneous and induced sputum for investigation of airway inflammation in chronic obstructive pulmonary disease.

Authors:  A Bhowmik; T A Seemungal; R J Sapsford; J L Devalia; J A Wedzicha
Journal:  Thorax       Date:  1998-11       Impact factor: 9.139

7.  Elastic contributions dominate the viscoelastic properties of sputum from cystic fibrosis patients.

Authors:  Heidi Nielsen; Søren Hvidt; Catherine A Sheils; Paul A Janmey
Journal:  Biophys Chem       Date:  2004-12-20       Impact factor: 2.352

Review 8.  Outcome measures for clinical trials in cystic fibrosis. Summary of a Cystic Fibrosis Foundation consensus conference.

Authors:  B W Ramsey; T F Boat
Journal:  J Pediatr       Date:  1994-02       Impact factor: 4.406

9.  Reference spirometric values using techniques and equipment that meet ATS recommendations.

Authors:  R O Crapo; A H Morris; R M Gardner
Journal:  Am Rev Respir Dis       Date:  1981-06

10.  Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis.

Authors:  E Pizzichini; M M Pizzichini; P Gibson; K Parameswaran; G J Gleich; L Berman; J Dolovich; F E Hargreave
Journal:  Am J Respir Crit Care Med       Date:  1998-11       Impact factor: 21.405

View more
  2 in total

1.  Persistent sputum cellularity and neutrophils may predict bronchiectasis.

Authors:  Nicole Drost; Liesel D'silva; Ryan Rebello; Ann Efthimiadis; Frederick E Hargreave; Parameswaran Nair
Journal:  Can Respir J       Date:  2011 Jul-Aug       Impact factor: 2.409

2.  Human neutrophils secrete bioactive paucimannosidic proteins from azurophilic granules into pathogen-infected sputum.

Authors:  Morten Thaysen-Andersen; Vignesh Venkatakrishnan; Ian Loke; Christine Laurini; Simone Diestel; Benjamin L Parker; Nicolle H Packer
Journal:  J Biol Chem       Date:  2015-02-02       Impact factor: 5.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.